Targeting TLK2 with antisense oligonucleotides as a new strategy in acute myeloid leukemiaH. J. Lin(Oregon Health & Science University), Anupriya Agarwal(Oregon Health & Science University)Frontiers in OncologyMarch 9, 202610.3389/fonc.2026.1659341Cited by 0SaveCiteExport RISWatch citationsRelated PapersOC7 Maralixibat-treated patients with Alagille syndrome demonstrate event-free survival in a natural history comparison with patients with from the GALA database: application of real-world evidence analytics|Abstracts|2023|0